Moderna price target raised to $120 from $67 at Goldman Sachs
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Goldman Sachs raises Moderna's target to $120 from $67; current price $174.38.
Target: $120
Posted price: $174.38
Analyst firm: Goldman Sachs
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.